Having demonstrated that PDI-1 effectively blocks PD-1/PD-L1-mediated suppression of anti-tumor cytotoxicity and cytokine production by human T cells ex vivo, we next determined whether PDI-1 would have beneficial effects on tumor growth in vivo. The gene discussed is CD274; the disease is neoplasm.